FDA recall D-0368-2019

Aurobindo Pharma USA Inc. · Class II · drug

Product

Valsartan and Hydrochlorothiazide tablets USP 80 mg/12.5 mg, 90-count bottle, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-547-90.

Reason for recall

CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

Distribution

Product was distributed to 25 distributors and Retail Chains who may have further distributed the product throughout the United States.

Key facts

Status
Ongoing
Initiation date
2018-12-31
Report date
2019-01-23
Voluntary/Mandated
Voluntary: Firm initiated
Location
East Windsor, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0368-2019